Real-World Outcomes of Immune Checkpoint Inhibitors in Lung Cancer: A Study from a Middle-Income Nation - Quiz - MDSpire

Real-World Outcomes of Immune Checkpoint Inhibitors in Lung Cancer: A Study from a Middle-Income Nation

  • By

  • Zineb Benbrahim

  • Oumaima Siyouri

  • Mohamed Fetohi

  • Nadia Benchakroun

  • Nabil Ismaili

  • Nssiba Bahra

  • Nabil Tachfouti

  • Brahim El Ghissassi

  • Fatima Zahra El M’Rabet

  • Rhizlane Belbaraka

  • Ali Tahri

  • Abdelkader Acharqi

  • Nawfel Mellas

  • January 26, 2026

  • 0 min

Share

Original Source(s)

Real-World Outcomes of Immune Checkpoint Inhibitors in Lung Cancer: A Study from a Middle-Income Nation

  • by Zineb Benbrahim, Oumaima Siyouri, Mohamed Fetohi, Nadia Benchakroun, Nabil Ismaili, Nssiba Bahra, Nabil Tachfouti, Brahim El Ghissassi, Fatima Zahra El M’Rabet, Rhizlane Belbaraka, Ali Tahri, Abdelkader Acharqi, Nawfel Mellas

  • January 26, 2026

Related Content

Real-world treatment patterns and outcomes for patients with extensive-stage small-cell lung cancer treated in US community oncology practices

Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer

Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases